(Press-News.org) Colorectal cancer is unique in having its own microbial ‘fingerprint’ – according to new research from the University of East Anglia.
Colorectal cancer is the fourth most common cancer in the UK and the second deadliest.
The research could help doctors better understand how this cancer develops, how aggressive it might be, and even how a patient might respond to treatment.
The team studied whole genome sequencing (WGS) data from more than 9,000 cancer patients.
The analysis, published today, also challenges scientific claims that all cancers are associated with a unique microbial fingerprint.
“This study changes how we think about the role of microbes in cancer,” said lead researcher Dr Abraham Gihawi, from UEA’s Norwich Medical School.
How the research happened
The research team studied Genomics England DNA sequence information from 11,735 cancer samples representing 22 different types of cancer.
“When you collect cancer DNA sequences, you also gain information from the DNA of microbes contained within the samples,” said Dr Gihawi.
“We wanted to determine the precise DNA composition of microbes present in each sample. So, we developed computer programs to remove human DNA and analyse the remaining microbe DNA.
“We then correlated this information with clinical data from the patients about their cancer type and clinical outcome.
“What we found challenges previous claims that each cancer type has a distinct microbiological signature or fingerprint.
“But importantly, as whole genome sequencing becomes more common in hospitals, we show that looking at the microbes in tumour samples could become a powerful tool for improving cancer care at little extra cost.
A breakthrough for colorectal and oral cancers
“Our results show that only colorectal tumours possess distinctly identifiable microbial communities.
“We found that these microbial signatures were so specific that they could accurately distinguish colorectal tumours from other tumours. We hope that this could help doctors diagnose the disease more precisely and researchers to study the microbes found in colorectal cancer.”
The study also uncovered promising clinical applications.
For example, in oral cancers, the study found that certain viruses like HPV (human papillomavirus) could be detected accurately compared with current medical tests.
The team also found rare but dangerous viruses, such as Human T-Lymphotropic Virus-1 (HTLV-1), which can be dormant infections capable of causing cancer.
Better survival rates
“We found that certain types of bacteria were associated with poorer survival rates in some cases of sarcoma. This might lead to additional research and treatment options for these types of cancer,” said Dr Gihawi.
“One of the most exciting things we found was that in some sarcoma cases, the presence of specific bacteria was linked to better survival rates.
“This suggests that microbes might one day help doctors predict how well a patient will respond to treatment and open up new approaches to treatment,” he added.
An indispensable tool
Prof Daniel Brewer, from UEA’s Norwich Medical School, said: “This study highlights the growing clinical value of whole genome sequencing in identifying pathogenic organisms such as HTLV-1 and papillomavirus, which may otherwise go undetected.
“By revealing these hidden infections and providing insight into cancer prognosis - particularly in sarcomas - it demonstrates how genomic analysis is becoming an indispensable tool in precision medicine.
“The findings also suggest that oral cancer, in some cases, may be a close diagnostic consideration, further emphasizing the importance of comprehensive genomic profiling in clinical decision-making.”
This research was led by UEA in collaboration with the University of Leeds, the Quadram Institute, Oxford Nanopore Technologies, the Institute of Cancer Research, London, the University of Manchester, NIHR Manchester Biomedical Research Centre, the University of Athens (Greece) the University of Liverpool, Cambridge University Hospitals NHS Foundation Trust, University College London, the University of Southampton, the University of North Carolina (US) and the Earlham Institute.
This work was funded by the Big C Cancer Charity and Prostate Cancer UK, with further support from The Bob Champion Cancer Trust, The Alan Boswell Group, Masonic Charitable Foundation Successor to the Grand Charity, Movember, Prostate Cancer Research, the King Family, the Hargrave Foundation, NIHR Manchester Biomedical Research Centre and Sarcoma UK.
‘Microbial Clues in Cancer: New Study Challenges Old Assumptions and Reveals Clinical Potential’ is published in the journal Science Translational Medicine.
END
DNA analysis shows colorectal cancer has unique microbial fingerprint
2025-09-03
ELSE PRESS RELEASES FROM THIS DATE:
Sugar-coated nanoparticles could target deadly breast cancer
2025-09-03
Triple-negative breast cancer is particularly aggressive and difficult to treat; but recent research may offer a new way to target the often-deadly disease.
A team of researchers from the University of Mississippi found that coating nanoparticles containing cancer therapies in a sugar-like substance makes them more effective in targeting this cancer. They published their research in Advanced Healthcare Materials.
“It’s called triple-negative because it does not have any of the three things that we have developed treatments to target in cancer,” said Eden Tanner, assistant professor of chemistry and biochemistry. ...
Understanding catalyst activity for green hydrogen production
2025-09-03
Key Aspects:
The study focuses on the oxygen evolution reaction, a key process in water electrolysis for hydrogen production.
Researchers identified a critical transition point in catalyst kinetics using a combination of temperature dependent kinetics and advanced spectroscopy techniques.
Findings suggest that the catalyst activity is related to the need for solvation of ions at the catalyst interface.
The research emphasizes the importance of viewing the catalyst-electrolyte interface as a unified system.
Introduction to Catalyst Activity
The Department ...
Zhu harnessing interpretable neuro-symbolic learning for reliable ranking
2025-09-03
Ziwei Zhu, Assistant Professor, Computer Science, College of Engineering and Computing (CEC), received funding for the project: “III: Small: Harnessing Interpretable Neuro-Symbolic Learning for Reliable Ranking.”
Zhu aims to forge novel neuro-symbolic learning to rank models to deliver interpretable, balanced, and robust rankings.
In this research, Zhu will introduce a neural network that transparently elucidates the entire inference process in ranking and presents a logic AutoEncoder, a type of artificial neural network for interpretable ...
George Mason researchers receive funding for Quantum System Stability & Reproducibility Workshop (StableQ)
2025-09-03
Weiwen Jiang, Assistant Professor, Electrical and Computer Engineering, College of Engineering and Computing (CEC), and Lei Yang, Assistant Professor, Information Sciences and Technology, CEC, received funding for a workshop on quantum system stability and reproducibility.
Jiang and Yang will use this funding to support students and researchers who participate in StableQ 2025. The event will bring together experts from academia, industry, and national laboratories to report state-of-the-art developments, exchange ideas and practices, and foster ...
Li studying quantum algorithms
2025-09-03
Li Studying Quantum Algorithms
Fei Li, Associate Professor, Computer Science, College of Engineering and Computing (CEC), received funding for the project: “Quantum Algorithms for High-Performance Analysis of Single-Cell Omics Data and Explainable Drug Discovery.”
This project leverages quantum computing to develop innovative, explainable methods for drug target discovery by integrating biological omics data—such as single-cell RNA sequencing (scRNA-seq) from disease tissue samples—with ex vivo drug ...
Chronic benzodiazepine consumption impacts sleep quality in older adults, new research shows
2025-09-03
Long-term use of benzodiazepine and related drugs has been linked to poorer quality sleep in older adults with insomnia. While they are cheap, commonly prescribed and widely available in Quebec, these drugs are also addictive: quitting cold turkey can lead to serious withdrawal symptoms, including increased risk of falls, hospitalization and cognitive issues.
A new study led by Concordia researchers published in the journal Sleep shows that use of benzodiazepine and benzodiazepine receptor agonists (BZRA) can also affect brain rhythms during sleep that are important for memory and cognitive health in adults aged between 55 and 80.
“These drugs don’t ...
USF-led Nature study: Gene defect slows brain’s cleanup, driving Alzheimer’s risk
2025-09-03
Key takeaways:
A PICALM gene variant disrupts microglia, the brain’s cleanup cells, reducing their ability to clear harmful proteins and lipids.
This dysfunction leads to lipid droplet buildup in microglia, weakening their protective role and raising Alzheimer’s risk.
The findings provide a roadmap for drug development targeting genetic risk factors in late-onset Alzheimer’s disease.
TAMPA, Fla. (Sept. 3, 2025) – A Nature study published today and led by researchers at the University of South Florida’s USF Health Byrd ...
Close link between street sweeps, overdose and systemic harm: SFU study
2025-09-03
Confiscating personal belongings during government-led dismantling of tent cities in Vancouver inflicts immediate harm and further destabilizes people already struggling to meet their basic needs, according to a new study from Simon Fraser University.
Published in the journal Public Health, the study found nearly one in four people experiencing homelessness reported having their personal belongings confiscated by city workers between 2021 and 2023. These confiscations—often part of street sweeps to remove tent cities—were significantly associated with non-fatal overdoses, violent victimization, and barriers to accessing essential services.
“Our data captures ...
New study seeks to understand the links between social drivers of health by investigating cardiovascular health in young adults
2025-09-03
FOR IMMEDIATE RELEASE, September 3, 2025
Contact: Gina DiGravio, 617-358-7838, ginad@bu.edu
New Study Seeks to Understand the Links between Social Drivers of Health by Investigating Cardiovascular Health in Young Adults
“Detailing childhood social determinants helps target those factors that drive cardiovascular disease in adulthood”
(Boston)—Cardiovascular disease (CVD) remains the leading cause of death and disability for adults in the U.S. Recent projections from the American Heart Association suggest that by 2050, more than 45 million American adults will have clinical CVD and more than 184 million will ...
New catalysis method can generate a library of novel molecules for drug discovery
2025-09-03
(Santa Barbara, Calif.) — Using reprogrammed biocatalysts, researchers are pushing the boundaries of enzymatic synthesis with a method that opens the door to a diverse array of valuable compounds. Reporting in the journal Science, UC Santa Barbara chemistry professor Yang Yang and collaborators detail an enzymatic multicomponent reaction, resulting in six distinct molecular scaffolds, many of which were not previously accessible by other chemical or biological methods.
“The ability to generate novelty and molecular diversity is particularly important to medicinal chemistry,” Yang said. “For a long time, biocatalysis ...